Dr Kevin Sek
Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology
12 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8 T cells in lymph nodes
DOI: 10.1038/s41590-026-02419-42025
Journal article
Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors
DOI: 10.1038/s41467-025-59021-92025
Journal article
Rewiring endogenous genes in CAR T cells for tumour-restricted payload delivery
DOI: 10.1038/s41586-025-09212-72024
Journal article
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy
DOI: 10.1038/s41586-024-07242-12023
Journal article
A2AR eGFP reporter mouse enables elucidation of A2AR expression dynamics during anti-tumor immune responses
DOI: 10.1038/s41467-023-42734-02023
Journal article
TSTEM-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models
DOI: 10.1126/scitranslmed.abk19002022
Journal article
PTP1B Is an Intracellular Checkpoint that Limits T-cell and CAR T-cell Antitumor Immunity
DOI: 10.1158/2159-8290.CD-21-0694
RECENT SCHOLARLY WORKS
2021
Journal article
Adoptive transfer of tumor-specific Th9 cells eradicates heterogeneous antigen-expressing tumor cells
DOI: 10.1016/j.ccell.2021.10.0132021
Journal article
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy
DOI: 10.1038/s41467-021-23331-52020
Journal article
IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors
DOI: 10.1016/j.ymthe.2020.07.018